| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Insmed (INSM) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The overall sentiment for Insmed is positive (overall 1.7, positive 3, negative -1.3) on 2025-11-19. The forces of Sentiment towards Fundamentals (2.4), Stock Price Trend (1.8), Option Sentiment (1.5), Sector Price Trend (0.4), and Valuation Sentiment (0) will drive up the price. The forces of Price Level Sentiment (-0.5), and Market Risk Appetite (-2) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3). The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Market Sentiment | Action | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 0% | 0% | 203.56 | 85 | 0.96% | 0.88% | 1.8 | 0.6 | Range | 2.4 | -1.5 |
| 2025-11-18 | 0% | 0% | 201.62 | 84 | 2.14% | 0.94% | 1.7 | 0.9 | Range | 1.9 | -1.5 |
| 2025-11-17 | 0% | 0% | 197.4 | 80 | 2.16% | 0.63% | 1.3 | 0.6 | Range | 1.2 | -1.5 |
| 2025-11-16 | 0% | 0% | 0.4 | 0.4 | Range | 1.2 | -1.5 | ||||
| 2025-11-15 | 0% | 0% | 0.4 | 0.3 | Range | 1.6 | -1.5 | ||||
| 2025-11-14 | 0% | 0% | 193.22 | 76 | 1.18% | 0.16% | 0.4 | 0.5 | Range | 1.6 | -1.5 |
| 2025-11-13 | 0% | 0% | 190.96 | 74 | -1.77% | -0.16% | 0.5 | 0.8 | Range | 1.9 | -1.5 |
| 2025-11-12 | 0% | 0% | 194.39 | 83 | 0.36% | 1.45% | 2.1 | 0.7 | Range | 0 | -1.5 |
| 2025-11-11 | 0% | 0% | 193.69 | 86 | 0.9% | 1.58% | 2.3 | 0.6 | Range | 0.9 | -1.5 |
| 2025-11-10 | 0% | 0% | 191.96 | 87 | 1.19% | 1.55% | 2 | 0.4 | Range | 1.4 | -1.5 |
| Trend sentiment reflects the price change, and market sentiment scores are calculated from many factors. Sentiment towards fundamentals and news sentiment are extracted from news headline. All sentiment scores are normalized in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. | Range refers to range trade strategy. In an uptrend, the price will likely bullback after huge advance. As an investor, you may want to wait for the pullback to open long position. As a trader, you may consider tactical short. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. As a trader, you may consider tactical long. |
| 2025-11-19 17:08:37 The approval of Brinsupri opens new market opportunities for Insmed, potentially providing a competitive edge in the lung disease treatment sector. |
| 2025-11-19 17:08:37 Insmed's new drug represents an innovation in treatments for non-cystic fibrosis bronchiectasis, indicating a growing trend in specialized healthcare solutions. |
| 2025-11-19 17:08:37 The rise in Insmed's stock price following the EU's approval signals positive investor sentiment and confidence in the company's future. |
| 2025-11-19 17:08:37 The successful phase III ASPEN and phase II WILLOW results highlight Insmed's effective development of its lung disease drug. |
| 2025-11-19 17:08:37 The approval of Brinsupri by the EU is a significant regulatory win for Insmed, indicating strong validation for its treatment. |